Published in J Clin Endocrinol Metab on September 01, 1983
Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats. J Clin Invest (1985) 0.97
Racial disparities in access to renal transplantation--clinically appropriate or due to underuse or overuse? N Engl J Med (2000) 4.67
Life-threatening thyrotoxicosis. Thyroid storm. Endocrinol Metab Clin North Am (1993) 3.71
"Hanging from the masthead": reflections on authorship. Ann Intern Med (1982) 3.42
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma. J Clin Endocrinol Metab (2003) 3.24
Sources of variability in repeated T-helper lymphocyte counts from human immunodeficiency virus type 1-infected patients: total lymphocyte count fluctuations and diurnal cycle are important. J Acquir Immune Defic Syndr (1990) 2.84
Discontinuing antithyroid drug therapy before ablation with radioiodine in Graves disease. Ann Intern Med (1994) 2.57
Overexpression and overactivation of Akt in thyroid carcinoma. Cancer Res (2001) 2.51
Graves' ophthalmopathy: current concepts regarding pathogenesis and management. Endocr Rev (1993) 2.23
Psychologic symptoms before and after parathyroid surgery. Am J Med (1994) 2.22
Thyrotropin-secreting pituitary tumors. Endocr Rev (1996) 2.21
Optimal use of blood tests for assessment of thyroid function. JAMA (1993) 2.00
Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab (2013) 1.89
The WHO quality of life assessment instrument (WHOQOL-Bref): the importance of its items for cross-cultural research. Qual Life Res (2001) 1.86
Akt activation and localisation correlate with tumour invasion and oncogene expression in thyroid cancer. J Med Genet (2004) 1.85
Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". Endocr Rev (1982) 1.81
Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science (1987) 1.79
Parental preferences in the management of vesicoureteral reflux. J Urol (2001) 1.69
Students with disabilities: a national survey of participation in school activities. Disabil Rehabil (2001) 1.63
Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy. J Clin Endocrinol Metab (1995) 1.62
Hormonal responses to graded surgical stress. Arch Intern Med (1987) 1.59
Sleep in the laboratory and sleep at home: comparisons of older insomniacs and normal sleepers. Sleep (1997) 1.51
Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1. Oncogene (2006) 1.45
Management of patients with thyroid carcinoma: application of thallium-201 scintigraphy and magnetic resonance imaging. J Nucl Med (1990) 1.41
Euthyroid hyperthyroxinemia. Ann Intern Med (1983) 1.40
The in vitro regulation of human thyrocyte HLA-DR antigen expression. J Clin Endocrinol Metab (1985) 1.40
Cinacalcet hydrochloride reduces the serum calcium concentration in inoperable parathyroid carcinoma. J Clin Endocrinol Metab (2007) 1.39
Current trends in the management of Graves' disease. J Clin Endocrinol Metab (1990) 1.39
The Caltrac accelerometer as a physical activity monitor for school-age children. Med Sci Sports Exerc (1990) 1.38
In vitro dissolution of calcium carbonate preparations. Calcif Tissue Int (1991) 1.38
Prognostic importance of vascular invasion in papillary thyroid carcinoma. Arch Otolaryngol Head Neck Surg (2000) 1.28
Immune mechanisms in Graves' disease. Endocr Rev (1985) 1.25
Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. Br J Surg (1986) 1.24
Refining the criterion for an abnormal Integrated Relaxation Pressure in esophageal pressure topography based on the pattern of esophageal contractility using a classification and regression tree model. Neurogastroenterol Motil (2012) 1.22
The euthyroid sick syndrome: is there a physiologic rationale for thyroid hormone treatment? J Endocrinol Invest (2003) 1.17
Influence of clinical characteristics and parameters associated with thyroid hormone therapy on the bone mineral density of women treated with thyroid hormone. Thyroid (1994) 1.15
Failure of oral water loading and intravenous hypotonic saline to suppress plasma prolactin in man. J Clin Endocrinol Metab (1975) 1.15
Unusual types of thyroid neoplasms. Endocrinol Metab Clin North Am (1996) 1.13
Inherited medullary thyroid carcinoma: a final monoclonal mutation in one of multiple clones of susceptible cells. Science (1978) 1.10
The production and characterization of thyroid-derived T-cell lines in Graves' disease and Hashimoto's thyroiditis. Clin Immunol Immunopathol (1986) 1.10
Isolated thyrotropin deficiency with thyrotropin-releasing-hormone induced TSH secretion and thyroidal release. J Clin Endocrinol Metab (1976) 1.09
Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al. Endocrinology (2013) 1.08
Inhibition by iodine of the release of thyroxine from the thyroid glands of patients with thyrotoxicosis. J Clin Invest (1970) 1.08
Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein. Biochemistry (1993) 1.07
Fasting decreases thyrotropin responsiveness to thyrotropin-releasing hormone: a potential cause of misinterpretation of thyroid function tests in the critically ill. J Clin Endocrinol Metab (1983) 1.05
Solitary cerebellar metastasis from papillary thyroid carcinoma: a case report. Thyroid (1998) 1.05
Inherited antithrombin-III deficiency causing mesenteric venous infarction: a new clinical entity. Ann Surg (1975) 1.04
Low remission after therapy for Graves disease. Possible relation of dietary iodine with antithyroid therapy results. JAMA (1973) 1.02
Adjunctive cholestyramine therapy for thyrotoxicosis. Clin Endocrinol (Oxf) (1993) 1.01
TSH receptor gene expression in retroocular fibroblasts. J Endocrinol Invest (1994) 1.01
Management of patients with malignant thymoma. J Thorac Cardiovasc Surg (1984) 0.99
Multiple hamartoma syndrome (Cowden's disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). Am J Clin Pathol (1992) 0.99
Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. Ann Intern Med (1988) 0.99
Evaluation of surrogate markers of impending death in the galactosamine-sensitized murine model of bacterial endotoxemia. Lab Anim Sci (1999) 0.99
Metastatic occult follicular thyroid carcinoma. JAMA (1976) 0.99
Hyperthyroid heart disease. Clin Cardiol (2000) 0.98
Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells. J Clin Endocrinol Metab (1980) 0.97
The value of serum antimicrosomal antibody testing in screening for symptomatic postpartum thyroid dysfunction. Am J Obstet Gynecol (1988) 0.97
Current trends in the management of well differentiated papillary thyroid carcinoma. J Clin Endocrinol Metab (1996) 0.96
Immunohistochemical analysis of intrathyroidal lymphocytes in Graves' disease: evidence of activated T cells and production of interferon-gamma. Clin Immunol Immunopathol (1988) 0.95
Tall cell variant: an aggressive form of papillary thyroid carcinoma. Otolaryngol Head Neck Surg (2000) 0.94
Hemiagenesis of the thyroid gland. Am J Med (1975) 0.94
Measurement of serum T4 concentration by high performance liquid chromatography. J Clin Endocrinol Metab (1981) 0.94
Lithium-associated thyrotoxicosis. Am J Med (1986) 0.93
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up. J Clin Endocrinol Metab (2012) 0.92
Alterations in magnesium and zinc metabolism in thyroid disease. Metabolism (1988) 0.92
Polymerase chain reaction-based microsatellite polymorphism analysis of follicular and Hürthle cell neoplasms of the thyroid. J Clin Endocrinol Metab (1998) 0.91
Acromegaly and the heart. An echocardiographic study. Am J Med (1979) 0.91
Abnormalities of liver function tests in tyrotoxicosis. Mil Med (1978) 0.91
Ultrasound-guided fine-needle aspiration and thyroid disease. Otolaryngol Head Neck Surg (2000) 0.91
Pheochromocytoma. Urology (2001) 0.90
Persistent thyroid autoimmunity after subacute thyroiditis. J Clin Lab Immunol (1987) 0.90
Localizing the contractile deceleration point (CDP) in patients with abnormal esophageal pressure topography. Neurogastroenterol Motil (2012) 0.90
Endocrine function in human obesity. Metabolism (1981) 0.90
Acromegaly. Treatment by transsphenoidal microsurgery. JAMA (1975) 0.90
Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism. Am J Med (1981) 0.90
Do our methods lead to insomniacs' madness?: Daytime testing after laboratory and home-based polysomnographic studies. Sleep (1997) 0.89
Inadvertent ketamine overdose in children: clinical manifestations and outcome. Ann Emerg Med (1999) 0.89
Measurement of 3,3',5'-Triiodothyroinine (reverse T3), 3,3'-L-diiodothyronine, T3 and T4 in human amniotic fluid and in cord and maternal serum. J Clin Endocrinol Metab (1976) 0.88
The effect of T3 and reverse T3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Metabolism (1979) 0.88
Iodine effects on the thyroid gland: biochemical and clinical aspects. Rev Endocr Metab Disord (2000) 0.88
The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab (2001) 0.87